RXRA and breast cancer: In Figure 6B, α-selinene, methyl linoleate, α-terpineol, and methyl linolenate were associated with acute myeloid leukemia, hormonally-responsive breast cancer, Kaposi sarcoma, and cutaneous T-cell lymphoma by acting on the RXRA, CYP19A1, and AR.